Pro zobrazení tohoto obsahu je třeba být přihlášen.
Author Archives for m.popovic@wemakemedia.cz
Interest of short hormonotherapy (HT) associated with radiotherapy (RT) as salvage treatment for metastatic free survival (MFS) after radical prostatectomy (RP): Update at 9 years of the GETUG-AFU 16 phase III
18 septembra, 2020 8:01 pm Leave your thoughtsAuthors: Christian Carrie, Nicolas Magné, Patricia Burban-Provost, et. al. Abstract: 5001 Clinical Trial Registry Number: NCT00423475 Citation:...
Novel Targeted-Antibody Treatment Produced Responses in Nearly Half of Patients with Advanced Urothelial Cancer
18 septembra, 2020 8:01 pm Leave your thoughtsJune 3, 2019 “If advanced urothelial cancer progresses following treatment with platinum-based chemotherapy and immunotherapy with checkpoint inhibitors there are...
SPRÁVA Z VÝROČNEJ KONFERENCIE AMERICKEJ ONKOLOGICKEJ SPOLOČNOSTI 2019 Genitourinárne malignity
18 septembra, 2020 8:01 pm Leave your thoughtsV dňoch 1. – 5. júna 2019 sa v americkom Chicagu uskutočnila výročná konferencia Americkej onkologickej spoločnosti (ASCO®). Aj tento rok odzneli...
Baseline tumor-immune signatures associated with response to bempegaldesleukin (NKTR-214) and nivolumab
18 septembra, 2020 8:01 pm Leave your thoughtsAuthors: Michael E. Hurwitz, Daniel C. Cho, Arjun Vasant Balar, et. al. Abstract: 2623 Clinical Trial Registry Number:...
Association between baseline disease characteristics and relapse-free survival (RFS) in patients (pts) with BRAF V600-mutant resected stage III melanoma treated with adjuvant dabrafenib (D) + trametinib (T) or placebo (PBO)
18 septembra, 2020 8:00 pm Leave your thoughtsAuthors: Dirk Schadendorf, Reinhard Dummer, Axel Hauschild, et. al. Abstract: 9582 Citation: J Clin Oncol 37, 2019 (suppl;...
Five-year analysis on the long-term effects of dabrafenib plus trametinib (D + T) in patients with BRAF V600–mutant unresectable or metastatic melanoma
18 septembra, 2020 8:00 pm Leave your thoughtsAuthors: Paul D. Nathan, Caroline Robert, Jean Jacques Grob, et. al. Abstract: 9507 Clinical Trial Registry Number: NCT01584648;...
ASCO® 2019 – malígny melanóm Opäť krok dopredu
18 septembra, 2020 8:00 pm Leave your thoughtsMalígny melanóm bol roky v úzadí pri hodnotení príchodu nových metód terapie a inovatívnych preparátov. Len pred niekoľkými rokmi sa situácia obrátila...
Combination of niraparib and bevacizumab versus niraparib alone as treatment of recurrent platinum-sensitive ovarian cancer. A randomized controlled chemotherapy-free study—NSGO-AVANOVA2/ENGOT-OV24
18 septembra, 2020 8:00 pm Leave your thoughtsAuthors: Mansoor Raza Mirza, Elisabeth Avall-Lundqvist, Michael J. Birrer, et. al. Abstract: 5505 Clinical Trial Registry Number: NCT02354131...
Results from neoadjuvant chemotherapy followed by surgery compared to chemoradiation for stage Ib2-IIb cervical cancer, EORTC 55994
18 septembra, 2020 8:00 pm Leave your thoughtsAuthors: Gemma Kenter, Stefano Greggi, Ignace Vergote, et. al. Abstract: 5503 Clinical Trial Registry Number: NCT00039338 Citation:...
A randomized phase 3 trial of paclitaxel (P) plus carboplatin (C) versus paclitaxel plus ifosfamide (I) in chemotherapy-naive patients with stage I-IV, persistent or recurrent carcinosarcoma of the uterus or ovary: An NRG oncology trial
18 septembra, 2020 8:00 pm Leave your thoughtsAuthors: Matthew A. Powell, Virginia L. Filiaci, Martee Leigh Hensley, et. al. Abstract: 5500 Clinical Trial Registry Number:...